Furthermore, inflammatory cytokines (e.g., TNF-α and IL-6) impair insulin signaling, leading to insulin resistance, which stimulates liver fat synthesis and inhibits fat degradation, exacerbating liver steatosis (88). The gene discussed is INS; the disease is Hepatic steatosis.